Gilead Sciences Inc (GILD)

67.22
-0.11(-0.16%)
After Hours
67.50
+0.28(+0.42%)
- Real-time Data
  • Volume:
    7,015,514
  • Bid/Ask:
    66.86/67.53
  • Day's Range:
    66.49 - 67.48

GILD Overview

Prev. Close
67.33
Day's Range
66.49-67.48
Revenue
25.56B
Open
67.32
52 wk Range
56.56-78.94
EPS
0.21
Volume
7,015,514
Market Cap
84.31B
Dividend (Yield)
2.84
(4.22%)
Average Volume (3m)
7,227,174
P/E Ratio
327.24
Beta
0.39
1-Year Change
-9.77%
Shares Outstanding
1,254,178,166
Next Earnings Date
Jul. 28, 2021
What is your sentiment on Gilead Sciences Inc?
or
Market is currently closed. Voting is open during market hours.

Gilead Sciences Inc News

Gilead Sciences Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralSellNeutralBuy
Technical IndicatorsStrong BuyStrong BuyStrong SellSellSell
SummaryNeutralBuyStrong SellNeutralNeutral

Gilead Sciences Inc Company Profile

Gilead Sciences Inc Company Profile

Employees
13600

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Read More
  • is it a buy right now or wait for any positive news?
    0
    • do you think Trump showing fast signs of recovery and also using Gilead medicine will cause the stock to go up?
      0
      • More fake news about Gilead to boost stocks lol
        0
        • Health canada hs approved remdesivir
          0
      • if theres a single complication its gonna crash like a plane. high risk high reward
        1
        • Exactly. Probably won't go down past 65 though where is was before all this.
          0
        • They just waiting for the results , if any step in positive direction then we will see a jump bigger than MRNA
          0
      • I hoping for a new record high
        0
        • how much gain do you guys think it will do?
          0
          • This one is gonna rocket!!
            0
            • FDA coming
              0
              • sponsored by Republicans. lol
                0
                • More fake news just wait😷
                  0
                  • Lolololol😷🤑. Had it right
                    0
                    • fake news
                      0
                      • Proof of fake news?
                        0
                      • the team that reported the result was funded by Gilead.
                        0
                    • Be careful this stock is riding on fake news😷🤑
                      0
                      • Got any links to back it up or just you're instinct ?
                        0
                      • Do your own research, trade cautiously. If it’s fake news then ride the wave and take what you can.
                        0
                    • any recommendations for price entry point and keeping it for how long?
                      0
                      • What is the good price for this
                        0
                        • why so quiet here
                          0
                          • Keep loading up $ONEM, future of personalized healthcare. Considering the coronavirus influence, One Medical is the gold. GILD is already too high
                            4
                            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.